According to MSTF media reports, immunologist Ugur Sahin, the founder and CEO of BioNTech and the 2019 Mustafa(pbuh) Prize laureate for his outstanding work on the development and clinical testing of ...
The COVID-19 vaccine developed by BioNTech, co-founded by the 2019 Mustafa (PBUH) Prize laureate Ugur Sahin, and Pfizer, is found to be more than 90% effective based on initial trial results, said ...
TEHRAN (Tasnim) – The COVID-19 vaccine developed by BioNTech, co-founded by the 2019 Mustafa (PBUH) Prize laureate Ugur Sahin, and Pfizer, is found to be more than 90% effective based on initial trial ...